ERBB2 and triple-negative breast carcinoma: Notably, breast cancer is a heterogeneous disease (1) with distinct molecular subtypes such as hormone receptor-positive (HR+), human epidermal growth factor receptor 2-positive (HER2+), and triple-negative breast cancer (TNBC) (2–4).